Presentation TCT 2016

The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status

Presenter: C. Michael Gibson

November 01, 2016

REGISTER for free or LOG IN to view this content

The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status

Heart Rhythm

Presentation

TCT 2016

Atrial Fibrillation

Up Next

Presentation TCT 2016

Update on Epidemiology, Prevention, Screening, and Control

Presenter: Bernard J. Gersh

November 01, 2016

More slides +

Presentation TCT 2016

TCT 518: The Interaction between Aortic and Coronary Pressures for Fractional Flow Reserve Value in Patients with an Intermediate Coronary Artery Stenosis

Presenter: Alan C. Yeung

November 01, 2016

Presentation TCT 2016

TCT 252: The Incidence, Determinants and Outcomes of Coronary Perforation During Percutaneous Coronary Intervention in the United Kingdom Between 20062013: an analysis of 527,121 Cases from the British Cardiovascular Intervention Society Database

Presenter: Mauricio G. Cohen

November 01, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.